Visuglican Eye Drops 10ml 40+2ml/ml,Visuglican Collirio 10ml 40+2ml/mlVISUFARMA SPA

“ACTIVE ingredients: Sodium cromoglycate; chlorphenamine maleate. Excipients: Medicine eye drops, solution in 10 ml bottles. 100 ml eye drops containing: sodium edetate; phosphate is needed; sodium phosphate; sodium et mercury tiosalicilato; purified water. The drug, Eye drops, solution in single-dose containers. 100 ml of eye drops contain: sodium edetate; phosphate is needed; sodium phosphate; purified water.
INDICATIONS: Treatment of conjunctivitis, toxic in nature, allergic and erythematous, for subacute and chronic work.
CONTRAINDICATIONS/EFF.SECONDARY: persons with hypersensitivity to the active substance or to any of the excipients.
DOSAGE: 1-2 drops into the conjunctival fornix, four times a day. Before use, ensure that the single dose container is not damaged. The drug in the single dose container should be used only immediately after opening. Leftovers should not be used. Prevent the end in’ of the container from coming into contact with the eye or any other surface.
STORAGE: Vial: Store at a temperature not exceeding 25 degrees C. Single dose and: Keep product away from heat sources.
WARNINGS: For use under the direct supervision of a physician. Do not use if the solution is not clear. The drug eye drops, solution in 10 ml bottles contains sodium etilmercurio tiosalicilato (mixture of organomer curie) as a preservative, which means ensibilizzazione reactions may occur.
INTERACTIONS: There are no known interactions with other drugs. However, additives can be performed when the drug is administered simultaneously with an H2-antagonist (cimetidine) and cortico.
SIDE EFFECTS: Peristalsis and burning sensations have been reported rarely. In these cases, it is recommended to suspend treatment. Reporting of suspicious adverse reactions that occur after the approval of a drug is important, as it allows tracking of accounts from the benefit/risk ratio of the drug.
PREGNANCY AND LACTATION: As with any medicine, and preferably whenever possible, avoid nistrazione during the first trimester of pregnancy. If use of this product is considered necessary in a nursing mother, the patient should discontinue breastfeeding.”